3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
127
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Burkitt Lymphoma
26
Myelodysplastic Syndromes
25
Leukemia
25
Leukemia, Biphenotypic, Acute
21
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
15
Lymphoma, Mantle-Cell
14
Recurrence
13
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Myeloproliferative Disorders
9
Lymphoma
9
Lymphoma, Non-Hodgkin
8
Leukemia, Myelomonocytic, Chronic
8
Lymphoma, Large B-Cell, Diffuse
7
Down Syndrome
6
Neoplasm, Residual
5
Hodgkin Disease
5
Blast Crisis
5
Sarcoma, Myeloid
4
Lymphoma, T-Cell
4
Leukemia, Monocytic, Acute
4
Hematologic Neoplasms
4
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Myeloid, Accelerated Phase
3
Neoplasms
2
Multiple Myeloma
2
Lymphoma, B-Cell
2
Interventions
zanubrutinib
1
pegaspargase
1
Rituximab
1
Methylprednisolone
1
Etoposide
1
Asparaginase
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
1 year
×
Clear all
No trials found.